The influence of medications on neurocognition in bipolar disorder.
Vieta
Eduard
E
D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000517:prevention & control / Q000523:psychology / Q000628:therapy; D018680:Cholinergic Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects*; D056344:Executive Function / Q000187:drug effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology / Q000627:therapeutic use; D009483:Neuropsychological Tests; D011588:Psychology, Educational; D012008:Recurrence; D016896:Treatment Outcome
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists; D006993:Hypnotics and Sedatives